Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 5.6B | 5.4B | 5.5B | 5.7B |
Cost of revenue | 4.2B | 4.0B | 4.2B | 4.3B |
Gross profit | 1.4B | 1.4B | 1.2B | 1.4B |
Operating expense | ||||
Research & development | 177M | 170M | 155M | 139M |
Selling general and admin | 733M | 701M | 803M | 708M |
Other operating expenses | — | — | — | — |
Operating income | 469M | 492M | 265M | 559M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | 115M |
Other income expense | — | — | — | — |
Pretax income | 401M | 415M | 158M | 414M |
Tax provision | 130M | 96M | 170M | 125M |
Net income | 238M | 344M | -575M | 289M |
Basic EPS | — | 0.6 | -0.7 | 0.5 |
Diluted EPS | — | 0.6 | -0.7 | 0.5 |
Basic average shares | — | 562.1M | 565.2M | 563.2M |
Diluted average shares | — | 562.1M | 565.2M | 563.2M |
EBITDA | 948M | 757M | 587M | 820M |
Net income from continuing op. | 271M | 319M | -12M | 289M |
Minority interests | 2M | -18M | 202M | -11M |
Preferred stock dividends | 0 | 0 | 0 | 0 |